newsfilter
← Latest News
Business Wire·

NanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ Transplants

August Issue of Lancet Medical Journal Features Breakthrough Study Decoding Immunological Challenges of Xenotransplantation NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for